Compare KOD & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KOD | SOC |
|---|---|---|
| Founded | 2009 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 795.5M | 648.0M |
| IPO Year | 2018 | N/A |
| Metric | KOD | SOC |
|---|---|---|
| Price | $22.87 | $4.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $22.29 | $17.00 |
| AVG Volume (30 Days) | 774.9K | ★ 9.0M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $208.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.92 | $3.72 |
| 52 Week High | $23.63 | $35.00 |
| Indicator | KOD | SOC |
|---|---|---|
| Relative Strength Index (RSI) | 67.24 | 29.46 |
| Support Level | $19.25 | $4.04 |
| Resistance Level | $23.63 | $4.89 |
| Average True Range (ATR) | 1.92 | 0.75 |
| MACD | 0.24 | 0.37 |
| Stochastic Oscillator | 89.70 | 14.73 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.